Sai Parenteral's Limited (NSE:SAIPARENT)
India · Delayed Price · Currency is INR 509.30
+2.65 (0.52%)
At close: Sep 23, 2026
Sai Parenteral's Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
Operating Revenue | 5,263 | 3,810 | 1,631 | 1,538 | 967.96 |
Other Revenue | 0.01 | 63.64 | 0.47 | -0 | - |
| 5,263 | 3,874 | 1,632 | 1,538 | 967.96 | |
Revenue Growth | - | 137.42% | 6.11% | 58.85% | - |
Cost of Revenue | 3,266 | 2,434 | 948.26 | 957.95 | 578.43 |
Gross Profit | 1,997 | 1,440 | 683.27 | 579.66 | 389.53 |
Selling, General & Admin | 375.68 | 303.61 | 141.06 | 131.95 | 98.71 |
Other Operating Expenses | 1,047 | 699.5 | 142.67 | 124.83 | 94.76 |
Operating Expenses | 1,657 | 1,172 | 365.77 | 356.76 | 251.4 |
Operating Income | 339.6 | 267.95 | 317.5 | 222.9 | 138.13 |
Interest Expense | -253.34 | -174.37 | -115.64 | -107.69 | -47.04 |
Interest & Investment Income | - | 4.53 | 3.08 | 2.34 | 1.91 |
Currency Exchange Gain (Loss) | - | 18.9 | -5.22 | 0.91 | -10.7 |
Other Non Operating Income (Expenses) | 110.87 | 2.27 | -3.19 | 7.58 | -9.79 |
EBT Excluding Unusual Items | 197.13 | 119.28 | 196.53 | 126.04 | 72.51 |
Pretax Income | 197.13 | 119.28 | 199.09 | 126.04 | 72.51 |
Income Tax Expense | -10.54 | -23.31 | 54.82 | 40.52 | 28.75 |
Earnings From Continuing Operations | 207.67 | 142.59 | 144.27 | 85.51 | 43.76 |
Earnings From Discontinued Operations | - | - | 0.27 | - | - |
Net Income to Company | 207.67 | 142.59 | 144.54 | 85.51 | 43.76 |
Minority Interest in Earnings | - | - | - | 4.66 | - |
Net Income | 207.67 | 142.59 | 144.54 | 90.17 | 43.76 |
Net Income to Common | 207.67 | 142.59 | 144.54 | 90.17 | 43.76 |
Net Income Growth | - | -1.35% | 60.30% | 106.05% | - |
Shares Outstanding (Basic) | 12 | 33 | 27 | 8 | 14 |
Shares Outstanding (Diluted) | 12 | 33 | 27 | 8 | 14 |
Shares Change | - | 22.81% | 232.47% | -43.83% | - |
EPS (Basic) | 17.89 | 4.36 | 5.43 | 11.26 | 3.07 |
EPS (Diluted) | 17.89 | 4.36 | 5.43 | 11.26 | 3.07 |
EPS Growth | - | -19.71% | -51.79% | 266.81% | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
Free Cash Flow | - | -1,369 | 326.49 | -746.38 | -285.4 |
Free Cash Flow Per Share | - | -41.88 | 12.27 | -93.23 | -20.02 |
Gross Margin | 37.94% | 37.16% | 41.88% | 37.70% | 40.24% |
Operating Margin | 6.45% | 6.92% | 19.46% | 14.50% | 14.27% |
Profit Margin | 3.95% | 3.68% | 8.86% | 5.86% | 4.52% |
Free Cash Flow Margin | - | -35.34% | 20.01% | -48.54% | -29.48% |
EBITDA | 529.74 | 431.36 | 399.54 | 316.96 | 196.06 |
EBITDA Margin | 10.07% | 11.14% | 24.49% | 20.61% | 20.26% |
D&A For EBITDA | 190.14 | 163.41 | 82.04 | 94.06 | 57.93 |
EBIT | 339.6 | 267.95 | 317.5 | 222.9 | 138.13 |
EBIT Margin | 6.45% | 6.92% | 19.46% | 14.50% | 14.27% |
Effective Tax Rate | - | - | 27.53% | 32.15% | 39.65% |
Revenue as Reported | 5,374 | 3,895 | 1,637 | 1,551 | 970.28 |
Advertising Expenses | - | - | - | 0.5 | 0.37 |